Lonza bags Personal Care Chemicals & Intermediates Technology Innovation Award
02 Aug '05
2 min read
Leading biotechnology Lonza received the Frost & Sullivan's 2005 Personal Care Chemicals & Intermediates Technology Innovation of the Year Award for its new pathbreaking Natrulon DermaSphereTM Oleosome Technology on 25 May 2005.
This technology represents a breakthrough in cosmetics formulation technologies.
The DermaSphereTM Oleosome Technology utilizes novel constituents – oleosomes – which facilitate the formulation of various cosmetics and personal care products with unique properties at competitive manufacturing costs.
It combines the benefits of an emollient, emulsifier and a moisturizer in a single product and offers the additional formulation manufacturing benefits of cold processing.
Frost & Sullivan's 2005 Award recognizes Lonza for this achievement and for its overall excellence in technology innovation in the field of personal care.
Lonza is a life sciences driven chemical and biotechnology company, headquartered in Switzerland, which generated sales of CHF 2.18 billion in 2004. 5700 people operating 18 production and R&D sites around the world are passionately delivering sustainable value to their customers.
Switzerland based Lonza is one of the leading custom manufacturers of chemical intermediates and active ingredients as well as biopharmaceuticals for the pharmaceutical and agrochemical industries. In addition, Lonza offers organic intermediates for a wide range of applications and provides antimicrobial and associated products as well as polymer intermediates and compounds.